TUCSON, Ariz., May 20, 2026 — Critical Path Institute® (C-Path) today announced the award of a $249,719 research grant to Odylia Therapeutics, a nonprofit biotechnology organization based in Atlanta.
TUCSON, Ariz., April 28, 2026 — Critical Path Institute® (C-Path) today announced a $456,000 grant to James Shayman, M.D., at the University of Michigan, to support development of a brain-penetrant ...
TUCSON, Ariz. and AMSTERDAM, March 26, 2026 /PRNewswire/ -- Critical Path Institute® (C-Path) today announced the launch of One to Millions, a global, multi-stakeholder public-private initiative to ...
TUCSON, Ariz., June 9, 2026 /PRNewswire/ -- Critical Path Institute® (C-Path) will host its 2026 Global Impact Conference (CGIC) this September at the Washington Marriott at Metro Center in Washington ...
Since its inception in Tucson, Arizona, C-Path has grown from a small team of six employees to a globally recognized leader that has generated more than 160 job opportunities to stimulate innovations ...
C-Path expands its worldwide leadership in accelerating drug development in neurology; seeks additional collaborators to broaden impact. TUCSON, Ariz., Nov. 13, 2024 /PRNewswire/ -- Critical Path ...
Global initiative to scale advanced therapeutic treatments to accelerate patient access worldwide. TUCSON, Ariz. and AMSTERDAM, March 26, 2026 /PRNewswire/ -- Critical Path Institute® (C-Path) today ...
Annual conference returns to Washington, D.C., Sept. 15-16; addresses challenges in establishing a new paradigm for how evidence of efficacy and safety is generated. CGIC 2026 convenes leaders across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results